Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOUBLE-SKIN: Haemoblock in Children With Vascular Pathology Undergoing Laser Surgery
NCT04999618Phase 4Completed
- Sponsor
- CVPath Institute
- Start
- Jan 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of haemoblock in burn injury and post-operative infection (2 arms), sponsored by CVPath Institute. Primary endpoint: Preventing negative outcomes of postoperative infection at 3 weeks. Started Jan 2020; status: completed.
02
Drugs
haemoblock
03
Conditions
burn injurypost-operative infection
Beyond the preview
Go deeper on NCT04999618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04999618.